Single-blind, randomized controlled trial evaluating the treatment of facial seborrheic dermatitis with hydrocortisone 1% ointment compared with tacrolimus 0.1% ointment in adults.
randomized
EVIDENCE COMPARISON
SupportiveLimited evidence suggests hydrocortisone and tacrolimus provide equal redness reduction for improving skin tone.
Effect ratio
Favored
Study
Comparison
Limits: Includes subjective endpoint
Direct comparison with enough study context for public-facing comparative wording, with limits noted for includes subjective endpoint.
The published evidence does not currently show a major generalization warning beyond the listed study limits.